Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database

被引:65
作者
Jones, R. [1 ]
Latinovic, R. [1 ]
Charlton, J. [1 ]
Gulliford, M. [1 ]
机构
[1] Kings Coll London, Sch Med, Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE11 6SP, England
关键词
BRONCHIAL HYPERRESPONSIVENESS; DIVERTICULAR-DISEASE; SYMPTOMS; EPIDEMIOLOGY; PREVALENCE; ALOSETRON; PATTERNS; THERAPY; WOMEN; TRIAL;
D O I
10.1111/j.1365-2036.2006.03044.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Irritable bowel syndrome is a common problem known to have a complex relationship with psychological disorders and other physical symptoms. Little information, however, is available concerning physical and psychological comorbidity in irritable bowel syndrome patients studied over an extended period. To evaluate physical and psychological morbidity 2 years before and during 6 years after the time of diagnosis in incident cases of irritable bowel syndrome and control subjects. A matched cohort study was implemented in 123 general practices using the General Practice Research Database. Irritable bowel syndrome cases (n = 1827) and controls (n = 3654) were compared for 2 years before and 6 years after diagnosis. The age-standardized incidence of irritable bowel syndrome in patients over 15 years of age was 1.9 per 1000 in men and 5.8 per 1000 in women. From 2 years before the date of diagnosis, more irritable bowel syndrome cases (13%) than controls (5%) consulted with depression or were prescribed antidepressant drugs. Consultation and prescription rates for anxiety were also higher before diagnosis, and both anxiety and depression remained prevalent up to 6 years after diagnosis. Asthma, symptoms of urinary tract infection, gall-bladder surgery, hysterectomy and diverticular disease were recorded more frequently in irritable bowel syndrome patients, who were also more likely than controls to be referred to hospital. People who are diagnosed with irritable bowel syndrome experience more anxiety and depression and a range of physical problems, compared with controls; they are more likely to be referred to hospital.
引用
收藏
页码:879 / 886
页数:8
相关论文
共 41 条
[1]  
[Anonymous], BRIT NAT FORM
[2]   Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [J].
Camilleri, M ;
Northcutt, AR ;
Kong, S ;
Dukes, GE ;
McSorley, D ;
Mangel, AW .
LANCET, 2000, 355 (9209) :1035-1040
[3]   A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome [J].
Camilleri, M ;
Chey, WY ;
Mayer, EA ;
Northcutt, AR ;
Heath, A ;
Dukes, GE ;
McSorley, D ;
Mangel, AM .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) :1733-1740
[4]   Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders [J].
Creed, F ;
Ratcliffe, J ;
Fernandes, L ;
Palmer, S ;
Rigby, C ;
Tomenson, B ;
Guthrie, E ;
Read, N ;
Thompson, DG .
BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 :507-515
[5]   A RANDOMIZED CONTROLLED TRIAL OF PSYCHOTHERAPY IN PATIENTS WITH REFRACTORY IRRITABLE-BOWEL-SYNDROME [J].
GUTHRIE, E ;
CREED, F ;
DAWSON, D ;
TOMENSON, B .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :315-321
[6]   Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review [J].
Henningsen, P ;
Zimmermann, T ;
Sattel, H .
PSYCHOSOMATIC MEDICINE, 2003, 65 (04) :528-533
[7]   Psychological factors in functional gastrointestinal disorders: Characteristics of the disorder or of the illness behavior? [J].
Herschbach, P ;
Henrich, G ;
von Rad, M .
PSYCHOSOMATIC MEDICINE, 1999, 61 (02) :148-153
[8]  
Heymann-Mönnikes I, 2000, AM J GASTROENTEROL, V95, P981
[9]   Irritable bowel syndrome - Patterns of ambulatory health care and resource use in the United States, 1993-1997 [J].
Hollowell, J ;
Lundgren, A ;
Johansson, S .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (05) :1115-1121
[10]   Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact [J].
Hungin, APS ;
Chang, L ;
Locke, GR ;
Dennis, EH ;
Barghout, V .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (11) :1365-1375